drugset / Trial / NCT00005999

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer

NCT00005999

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have stage IVB or recurrent cervical cancer.

Timeline

Start
2000-04
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule Intravenous

Indications